Kardium unveils further pivotal trial results for Globe PFA system
Kardium has unveiled further results from the pivotal trial of its Globe Pulsed Field System, demonstrating the system’s success in…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
2026: The time for AI to really deliver
In 2026, clinical trial design will be reshaped by artificial intelligence (AI)-powered simulation and richer clinical and real-world data. Improvements…
-
JPM26: Anthropic advances healthcare presence with new AI toolkit
Anthropic has introduced Claude for Healthcare, a suite of artificial intelligence (AI)-based tools to assist healthcare providers, payers, and patients…
-
Reeves’ Autumn Budget targets community health centres and NHS tech outlay
During the UK’s Autumn Budget, Rachel Reeves has unveiled further technology investments for the UK’s National Health Service (NHS) and,…
-
Sophia Genetics and Element partner to advance precision medicine research
Sophia Genetics and Element Biosciences have teamed up to advance genomic sequencing and workflows for precision medicine. Announced during the…
-
MMI wins IDE for surgical robotic Alzheimer’s disease study
US-based robotics company Medical Microinstruments (MMI) has obtained an investigational device exemption (IDE) from the US Food and Drug Administration…
-
The early phase advantage: the key to de-risking your clinical trials
In drug development, the earliest phases carry both the greatest uncertainty and the greatest opportunity. Early phase clinical trials, whether…
-
BCI implant’s trial success prefigures ‘new era’ in eye care
An electronic eye implant is giving hope to individuals who have experienced visual impairment due to dry age-related macular degeneration…
-
FDA greenlight for Roche’s Alzheimer’s disease test sparks care paradigm shift
The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost therapeutic intervention options…
-
Advancing patient registries and expanding real world evidence through technology
Patient registries are evolving from static data repositories to become valuable sources of real world evidence (RWE), which is increasingly…